Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma
Hepatocellular carcinoma is the third most common cause of cancer-related mortality. In recent years, transarterial chemoembolization, radio frequency ablation and microwave ablation have been accepted as treatment modalities for patients with surgically unresectable hepatocellular carcinoma.
Liver Cancer
DRUG: Transarterial chemoembolization (TACE)|PROCEDURE: Radiofrequency ablation combined with TACE|PROCEDURE: Microwave ablation combined with TACE
Number of patients with successful ablation, The total number of patients with successful ablation, 3 months
To compare between combination treatment with radiofrequency or microwave ablation followed by transarterial chemoembolization and performed in a single session.